MBP metabolic pharmaceuticals limited

Current Market Cap: $180 Millions - reasonable levelShare price:...

  1. 3,762 Posts.
    lightbulb Created with Sketch. 202
    Current Market Cap: $180 Millions - reasonable level

    Share price: $0.78 - 52 week low - potential rebound

    Daily Avg. Volume for 2005 till 10th March: 740K
    Friday's action 11th March: 2.73Millions - 3.7x the daily volume suggest it is oversold or turnaround point for the share price

    Substaintial Holders: Acorn Holder 5.19%, Polychip Pharmaceuticals 20.99%, Monash Investment 9.48% - none of these holders have sold suggest faith with the product & company - a good sign

    Cash as at Dec. 31st 04 - approx. $11Millions+ - healthy position

    Obsesity drugs - none available at this stage in the market has no side effect. If MBP can crack this, the company will become an instant $1Billion market cap. That is share price around $4.30.

    Partnership/Deals - Potential deal announcement anytime

    Management - New CEO, a turning point for the company. Currently presenting MBP to the US and now doing roadshows in Australia. Action on Friday suggest maybe Fund Managers oversea and local are convinced that the product does work and have faith with the new CEO.

    All in all, I believe the share price should recover above the $1 mark early next week.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.